Mounjaro on the NHS: What You Need to Know About Access and Guidelines

Mounjaro (tirzepatide) is a prescription-only medicine used for weight management and, in some settings, for blood glucose control in adults with type 2 diabetes. Because it is prescription-only, it cannot be obtained without a valid prescription from a qualified prescriber — regardless of the healthcare system or country involved.

NHS England guidelines and eligibility

In England, NHS guidance on tirzepatide for weight management has been phased in gradually, with access typically tied to specific clinical criteria such as body mass index thresholds, the presence of weight-related health conditions, and referral through specialist services. Guidelines also exist for its use in type 2 diabetes management. If you are wondering whether you meet the criteria under your healthcare system, that is a conversation for your prescriber or doctor — they can assess your full medical history and advise accordingly. You can read more about who may be eligible for Mounjaro through the NHS and review the clinical criteria used in NHS prescribing decisions.

Private prescriptions and other routes

Where NHS access is not available — for instance, if a person does not currently meet NHS criteria — some people obtain Mounjaro via a private prescription through a registered pharmacy. GLP Trackr does not sell, supply, or source Mounjaro or Wegovy through any route, and we do not name or recommend specific pharmacies or prescribing services. If you are exploring access options, a registered healthcare professional in your country is the right starting point.

Mounjaro for specific conditions

Questions about Mounjaro for conditions such as type 2 diabetes or PCOS are best directed to a specialist or prescriber who can assess whether it is appropriate for your individual circumstances. Suitability is always an individual clinical decision. For a broader overview of how Mounjaro costs and access intersect, see our guide on Mounjaro pricing and what affects it.

Once you have a prescription and are taking Mounjaro, staying consistent week to week makes a real difference — and that is exactly where GLP Trackr is built to help.

The most directly relevant feature for people navigating a prescribed course is dose and injection logging. Every time you administer your weekly injection, you can record the dose strength, date, time, and injection site in the app. Over weeks and months, this builds a complete picture of your treatment history — genuinely useful if your prescriber wants to review how your titration has progressed or if you ever need to recall when your last dose was taken.

If you experience side effects — whether nausea, fatigue, digestive changes, or anything else commonly reported with tirzepatide — the side-effect tracker lets you log symptoms and spot patterns over time. That kind of structured record is far easier to bring to a prescriber appointment than trying to recall how you felt three weeks ago. You can also explore what Mounjaro side effects on the NHS pathway are commonly reported and how to track them effectively.

Every decision about your dose, your titration schedule, or any change to your treatment belongs with your prescriber — GLP Trackr is a companion for logging and tracking, not a substitute for clinical guidance. If you experience anything severe, persistent, or worrying, contact your healthcare professional promptly.

Ready to make the most of your prescribed treatment? Download GLP Trackr on the App Store or Google Play and start a free 7-day trial — log your doses, track how you feel, and bring better records to every prescriber appointment.